全球智慧型胰岛素笔市场规模、份额、成长分析、按产品、按连接类型、按适应症、按最终用户 - 产业预测 2024-2031

2022年全球智慧胰岛素笔市场规模为36.6亿美元，预计将从2023年的40.3亿美元增至2031年的86.3亿美元，预测期（2024-2031）复合年增长率为10% ）。

智慧胰岛素笔透过促进糖尿病患者外部注射胰岛素，为糖尿病管理提供了卓越的解决方案。这些笔配备了及时提醒和警报等功能，确保定期给药。其用户友好的设计正在推动其越来越受欢迎。智慧胰岛素笔可以轻鬆连接到现有的胰岛素笔，从而增强其功能。智慧胰岛素笔的市场正在扩大，因为它们能够及时发出正确胰岛素剂量的警报和提醒，并监控错过的剂量，这对糖尿病患者至关重要。这些设备还可以透过监测特定时间和日期的血糖水平来帮助记录患者的糖尿病概况。此外，他们还监控胰岛素温度范围和有效期，以确保患者安全。然而，COVID-19大流行对智慧胰岛素笔市场产生了重大负面影响，因为严格的封锁措施和限制行动阻碍了实验室检测和糖尿病服务的获得，从而限制了市场成长。

目录

执行摘要

• 市场概况
• 命运之轮

研究方法论

• 资讯采购
• 二手和主要资料来源
• 市场规模估计
• 市场假设与限制

母公司市场分析

• 市场概况
• 市场规模
• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战

主要市场洞察

• 技术分析
• 定价分析
• 供应链分析
• 价值链分析
• 市场生态系统
• 智慧财产权分析
• 贸易分析
• 启动分析
• 原料分析
• 创新矩阵
• 管道产品分析
• 总体经济指标
• 顶级投资分析
• 成功的关键因素
• 竞争程度

市场动态与展望

• 市场动态
  • 司机
  • 机会
  • 限制
  • 挑战
• 监管环境
• 波特分析
• 对未来颠覆的特别见解

全球智慧胰岛素笔市场（按产品）

• 市场概况
• 智慧胰岛素笔
• 传统笔的适配器

按连接类型分類的全球智慧胰岛素笔市场

• 市场概况
• 蓝牙
• USB

按适应症分類的全球智慧胰岛素笔市场

• 市场概况
• 1 型糖尿病
• 2型糖尿病

全球智慧胰岛素笔市场（按最终用户）

• 市场概况
• 医院和诊所
• 门诊手术中心
• 家庭护理设置

按地区分類的全球智慧胰岛素笔市场

• 市场概况
• 北美洲
• 欧洲
• 亚太
• 拉丁美洲
• 和MEA

全球智慧型胰岛素笔市场规模（按地区）

• 市场概况
• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 拉丁美洲其他地区
• 中东和非洲 (MEA)
  • 海湾合作委员会国家
  • 南非
  • MEA 的其余部分

竞争格局

• 前 5 名玩家比较
• 2023 年关键参与者的市场定位
• 主要市场参与者所采取的策略
• 最佳制胜策略
• 近期市集活动
• 主要公司市占率 (%), 2023

主要公司简介

• Emperra GmbH
• Novo Nordisk A/S
• Medtronic plc
• Eli Lilly and Companya
• Sanofi SAa
• Companion Medical Inc.a
• Diabnexta
• Insulet Corporationa
• Pendiq GmbHa
• Digital Medics Pty Ltd.a
• F. Hoffmann-La Roche AGa
• Ypsomed AGa
• Common Sensing Inc.a
• InjexUK Ltd.a
• Diamesco Co., Ltd.a
• Nipro Corporationa
• Jiangsu Delfu Co., Ltd.a
• Wockhardt Ltd.a
• Biocon Ltd.

Global smart insulin pens market size was valued at USD 3.66 billion in 2022 and is expected to rise from USD 4.03 billion in 2023 to reach a value of USD 8.63 billion by 2031, at a CAGR of 10% during the forecast period (2024-2031).

Smart insulin pens offer a superior solution for managing diabetes by facilitating the external administration of insulin to diabetic patients. These pens are equipped with features such as timely reminders and alerts, ensuring regular dosing schedules. Their user-friendly design is driving their increasing popularity. Smart insulin pens can be easily attached to existing insulin pens, enhancing their functionality. The market for smart insulin pens is expanding due to their ability to provide timely alerts and reminders for correct insulin dosage, as well as monitoring missed doses, which is crucial for diabetic patients. These devices also help in maintaining a record of the patient's diabetes profile by monitoring blood sugar levels at specific times and dates. Additionally, they monitor insulin temperature ranges and expiry dates to ensure patient safety. However, the COVID-19 pandemic had a significant negative impact on the smart insulin pen market, as strict lockdown measures and restricted movement hindered access to laboratory testing and diabetic services, thereby limiting market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the global smart insulin pens market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Insulin Pens Market Segmental Analysis

The global smart insulin pens market is segmented based on product, connectivity type, indication, end-user, and region. By product, the market is segmented into smart insulin pens, and adaptors for conventional pens. By connectivity type, the market is segmented into bluetooth, and USB. By indication, the market is segmented into type 1 diabetes, type 2 diabetes. By end-user, the market is segmented into hospitals & clinics, ambulatory surgical centers, and home care settings. By region, the market is segmented into North America, Europe, Asia-Pacific, Latin America, and MEA.

Drivers of the Global Smart Insulin Pens Market

The increasing prevalence of diabetes, coupled with the demands of modern life and a growing workload, has led to a surge in the demand for insulin products. In response to this trend, smart insulin pens have emerged as a popular solution. With people facing increasingly hectic schedules, keeping track of diabetes readings and insulin dosing schedules has become more challenging. Smart insulin pens offer a technological solution to these challenges, making it easier for individuals to manage their diabetes effectively. Furthermore, the rise in needle stick injuries has contributed to the growing popularity of smart insulin pens. Manufacturers in the smart insulin pen market are capitalizing on this trend by expanding their production globally, aiming to generate significant revenues in the coming years.

Restraints in the Global Smart Insulin Pens Market

The global market demand for smart insulin pens could be negatively impacted by their high cost. In regions like Africa, where healthcare infrastructure is often inadequate and reimbursement policies are poor, patients may face significant barriers to accessing modern medical devices like smart insulin pens. As a result, the affordability of these devices becomes a key concern, limiting their uptake among populations in developing countries. This issue highlights the importance of addressing cost barriers and improving access to innovative healthcare solutions for underserved communities worldwide.

Market Trends of the Global Smart Insulin Pens Market

The global smart insulin pens market is experiencing key industry trends driven by increasing advancements in research and development activities within the healthcare sector. As the number of diabetic patients worldwide continues to rise, there is a growing demand for innovative solutions to manage the condition effectively. Market manufacturers are responding to this demand by introducing new and innovative products in the smart insulin pens segment. These developments are projected to create lucrative growth opportunities for the market in the long run, as they address the evolving needs of diabetic patients and healthcare providers alike.

Table of Contents

Executive Summary

• Market Overview
• Wheel of Fortune

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Parent Market Analysis

• Market Overview
• Market Size
• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges

Key Market Insights

• Technology Analysis
• Pricing Analysis
• Supply Chain Analysis
• Value Chain Analysis
• Ecosystem of the Market
• IP Analysis
• Trade Analysis
• Startup Analysis
• Raw Material Analysis
• Innovation Matrix
• Pipeline Product Analysis
• Macroeconomic Indicators
• Top Investment Analysis
• Key Success Factor
• Degree of Competition

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Regulatory Landscape
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers
• Skyquest Special Insights on Future Disruptions
  • Political Impact
  • Economic Impact
  • Social Impact
  • Technical Impact
  • Environmental Impact
  • Legal Impact

Global Smart Insulin Pens Market by Product

• Market Overview
• Smart insulin pen
• adaptors for conventional pen

Global Smart Insulin Pens Market by Connectivity typea

• Market Overview
• Bluetooth
• and USB

Global Smart Insulin Pens Market by Indication

• Market Overview
• Type 1 diabetes
• type 2 diabetes

Global Smart Insulin Pens Market by End-user

• Market Overview
• Hospitals & clinics
• ambulatory surgical centers
• home care settings

Global Smart Insulin Pens Market by Region

• Market Overview
• North America
• Europe
• Asia-Pacific
• Latin America
• and MEA

Global Smart Insulin Pens Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Top Winning Strategies
  • By Development
  • By Company
  • By Year
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• Emperra GmbH
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk A/S
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Companya
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi S.A.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Companion Medical Inc.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diabnexta
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporationa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pendiq GmbHa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Digital Medics Pty Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AGa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed AGa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Common Sensing Inc.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• InjexUK Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Diamesco Co., Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporationa
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Jiangsu Delfu Co., Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Wockhardt Ltd.a
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Biocon Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments